Subscribe
Dr. Reddy's Laboratories and Merck Serono, a division of Merck KGaA, have partnered to codevelop a portfolio of biosimilar compounds in oncology.
Developing Discoveries into New Therapeutics
GSK Collaborates on New Class of Medicines
